Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Ostergaard

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
The New Phytologist|December 8, 2020
Total FLC transcript dynamics from divergent paralogue expression explains flowering diversity in Brassica napusAlexander Calderwood, Andrew Lloyd, Jo Hepworth, et al.
The Lancet. Child & Adolescent Health|June 18, 2026
Immunogenicity and safety of a pentavalent meningococcal MenABCWY vaccine in healthy adolescents and young adults: a phase 3, multicountry, randomised, observer-blinded, active-controlled non-inferiority trialLars Ostergaard, Hanna Czajka, Lilia Roque-Guerrero, et al.
The Journal of Infectious Diseases|December 25, 2012
Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failureJonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.
Plos One|January 10, 2014
T cells detect intracellular DNA but fail to induce type I IFN responses: implications for restriction of HIV replicationRandi K Berg, Stine H Rahbek, Emil Kofod-Olsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2013
IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replicationMartin R Jakobsen, Rasmus O Bak, Annika Andersen, et al.
JAMA|April 7, 2011
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysisJonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 15, 2013
Immunogenicity, efficacy, safety, and mechanism of action of epitope vaccine (Lu AF20513) for Alzheimer's disease: prelude to a clinical trialHayk Davtyan, Anahit Ghochikyan, Irina Petrushina, et al.
AIDS (London, England)|November 8, 2017
Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?Amanda Mocroft, Kamilla Laut, Peter Reiss, et al.
The New England Journal of Medicine|December 14, 2017
A Bivalent Meningococcal B Vaccine in Adolescents and Young AdultsLars Ostergaard, Timo Vesikari, Judith Absalon, et al.
BMJ Open|December 30, 2022
Cohort Profile:The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE)Nina Breinholt Stærke, Joanne Reekie, Isik S Johansen, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
The New Phytologist|December 8, 2020
Total FLC transcript dynamics from divergent paralogue expression explains flowering diversity in Brassica napusAlexander Calderwood, Andrew Lloyd, Jo Hepworth, et al.
The Lancet. Child & Adolescent Health|June 18, 2026
Immunogenicity and safety of a pentavalent meningococcal MenABCWY vaccine in healthy adolescents and young adults: a phase 3, multicountry, randomised, observer-blinded, active-controlled non-inferiority trialLars Ostergaard, Hanna Czajka, Lilia Roque-Guerrero, et al.
The Journal of Infectious Diseases|December 25, 2012
Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failureJonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.
Plos One|January 10, 2014
T cells detect intracellular DNA but fail to induce type I IFN responses: implications for restriction of HIV replicationRandi K Berg, Stine H Rahbek, Emil Kofod-Olsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2013
IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replicationMartin R Jakobsen, Rasmus O Bak, Annika Andersen, et al.
JAMA|April 7, 2011
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysisJonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 15, 2013
Immunogenicity, efficacy, safety, and mechanism of action of epitope vaccine (Lu AF20513) for Alzheimer's disease: prelude to a clinical trialHayk Davtyan, Anahit Ghochikyan, Irina Petrushina, et al.
AIDS (London, England)|November 8, 2017
Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?Amanda Mocroft, Kamilla Laut, Peter Reiss, et al.
The New England Journal of Medicine|December 14, 2017
A Bivalent Meningococcal B Vaccine in Adolescents and Young AdultsLars Ostergaard, Timo Vesikari, Judith Absalon, et al.
BMJ Open|December 30, 2022
Cohort Profile:The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE)Nina Breinholt Stærke, Joanne Reekie, Isik S Johansen, et al.
Pageof 8